InSphero provides the 3D InSight™ Human Neural Microtissues platform to study neuronal network activity and compound-induced functional changes in a scalable 3D system.
Published
Signal category
Products & Services
Quote
“Our 3D InSight™ Human Neural Microtissues provide an assay-ready platform to study neuronal network activity and compound-induced functional changes in a scalable 3D system.”
— InSphero team
Company
InSphero
Reliable, reproducible, and scalable 3D in vitro platforms for drug safety & efficacy testing | The Model of Excellence™
- Industry
- Biotechnology Research
- Location
- Schlieren, CH
- Company size
- 82 employees
InSphero is the only 3D in vitro model company with the platform and expertise to modernize drug safety and efficacy testing in a way that empowers researchers to reach their full potential. Our innovative spheroid-based models allow for more effective and safe therapies to get to the clinic faster due to our superior robustness, reliability, reproducibility, and scalability. InSphero’s goal is to help researchers fuel a new era of drug discovery through comprehensive products and services for: - Liver safety - Liver disease - Islet Biology - Oncology & Immunology
Founded 2009